ArticleExperimental cell research2023

Corrigendum to "iPS-derived neural stem cells for disease modeling and evaluation of therapeutics for mucopolysaccharidosis type II" [Exp. Cell Res. 412, Issue 1, 1 March 2022, 113007].

Junjie Hong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.